Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same
AssigneeAjinomoto Co., Inc.
InventorsKatsutoshi Sakata, Takashi Tsuji, Munetaka Tokumasu, Kazuyoshi Takahashi, Shigeo Hirasawa, Junko Ezaki
Life of this patent
Estimating the term…
Abstract
The present invention provides dihydrodiaryloxazepine derivative represented by the following formula [1], analogs thereof and pharmaceutical compositions containing them. Those compounds have an excellent effect of improving functional diseases of gastrointestinal tracts. 1
Claims37
5,11-dihydrodiaryl[b,e][1,4]oxazepine derivatives represented by the following general formula [I], stereoisomers thereof, pharmacologically acceptable salts thereof, and hydrates or solvates thereof:
- 95
- wherein rings G, J and K each represent benzene ring or a nitrogen-containing aromatic ring;
- R1 R8 may be the same or different from one another and they each represent a halogen atom or hydrogen atom, R9 to R13 may be the same or different from one another and they each represent a hydrogen atom, a halogen atom, cyano group, hydroxyl group, a lower alkyl group, a lower alkoxyl group, amino group or a lower alkylamino group or a lower acylated derivative of such a group, a lower dialkylamino group or a cycloalkylamino group, or R9 and R10 or R10 and R11 together form —O(CH2)nO— group wherein n is 1, 2 or 3;
- A represents CH2, CHOH, CO or O;
- B represents CH2, CHOH or CO;
- or A-B represents CH═CH, D represents CH2, CH2—CH2 or CH2—CH2—CH2 or B-D represents CH2;
- X and Z are bonded together to form CH2—CH2 or CH2—CH2—CH2 and, in this case, Y represents a hydrogen atom;
- or Y and Z are bonded together to form CH2—CH2—CH2 or CH2—CH2—CH2—CH2 and, in this case, X represents a hydrogen atom;
- and when X and Z, and Y and Z are not bonded together, X and Y each represent a hydrogen atom and Z represents a lower alkyl group;
- provided that when any of R9 to R13 represents a cyclic amino group of the following formula [E], R1 to R8 may be a halogen atom or hydrogen atom but when none of R9 to R13 is a cyclic amino group of formula [E], one or two of R1 to R8 represent a halogen atom and the others represent a hydrogen atom:
- 96
- wherein n and m each represent 1 or 2, and W represents carbon atom, or nitrogen which may be substituted with a lower alkyl group, or oxygen, or sulfur atom.
5,11-Dihydrodiaryl[b,e][1,4]oxazepine derivatives represented by the following general formula [XV], stereoisomers thereof and salts thereof:
- 97
- wherein rings G, J and K each represent benzene ring or a nitrogen-containing aromatic ring;
- R1 R8 may be the same or different from one another and they each represent a halogen atom or a hydrogen atom, R9 to R13 may be the same or different from one another and they each represent a hydrogen atom, a halogen atom, cyano group, hy6droxyl group, a lower alkyl group, a lower alkoxyl group, amino group or a lower alkylamino group or a lower acylated derivative of such a group, a lower dialkylamino group or a cycloalkylamino group, or R9 and R10 or R10 and R11 together form —O(CH2)nO— group wherein n is 1, 2 or 3;
- L1 represents CH2, CHOH or O;
- L2 represents CH2, CHOH, CH2—CH2, CHOH—CH2, CH2—CH2—CH2 or CHOH—CH2—CH2;
- or L1 and L2 are bonded together to form CH2, CHOH or CH═CH, Y and Z are bonded together to form CH2—CH2—CH2 or CH2—CH2—CH2—CH2 or when Y and Z are not bonded together, Y represents a hydrogen atom and Z represents a lower alkyl group;
- provided that when any of R9 to R13 represents a cyclic amino group of the following formula [E], R1 to R8 may be a halogen atom or hydrogen atom but when none of R9 to R13 is a cyclic amino group of formula [E], one or two of R1 R8 represent a halogen atom and the others represent a hydrogen atom:
- 98
- wherein n and m each represent 1 or 2, and W represents carbon atom, or nitrogen which may be substituted with a lower alkyl group, or oxygen, or sulfur atom.
Amide derivatives of general formulae [XVI], stereoisomers thereof and salts thereof:
- 99
- wherein rings G, J and K each represent benzene ring or a nitrogen-containing aromatic ring;
- R1 to R8 may be the same or different from one another and they each represent a halogen atom or hydrogen atom, R9 to R13 may be the same or different from one another and they each represent a hydrogen atom, a halogen atom, cyano group, hydroxyl group, a lower alkyl group, a lower alkoxyl group, amino group or a lower alkylamino group or a lower acylated derivative of such a group, a lower dialkylamino group or a cycloalkylamino group, or R9 and R10 or R10 and R11 together form —O(CH2)nO— group wherein n is 1, 2 or 3;
- L1 represents CH2, CHOH or O;
- L2 represents CH2, CHOH, CH2—CH2, CHOH—CH2, CH2—CH2—CH2 or CHOH—CH2—CH2;
- or L1 and L2 are bonded together to form CH2, CHOH or CH═CH, Y and Z are bonded together to form CH2—CH2—CH2 or CH2—CH2—CH2—CH2 or wnen Y and Z are not bonded together, Y represents a hydrogen atom and Z represents a lower alkyl group;
- provided that when any of R9 to R13 represents a cyclic amino group of the following formula [E], R1 to R8 may be a halogen atom or hydrogen atom but when none of R9 to R13 is a cyclic amino group of formula [E], one or two of R1 to R8 represent a halogen atom and the others represent a hydrogen atom:
- 100
- wherein n and m each represent 1 or 2, and W represents carbon atom, or nitrogen which may be substituted with a lower alkyl group, or oxygen, or sulfur atom.
(R)-{[2-(3-Chloro-5,11-dihydrodibenzo[b,e][1,4]oxazepine-5-carbonyl)pyrrolidine]-1-yl}-2-(4-dimethylaminophenyl)ethanone, and stereoisomers and salts thereof.
(R)-1-[(4-Dimethylaminophenyl)acetyl]pyrrolidine-2-carboxylic acid [2-(2-bromo-4-chlorobenzyloxy)phenyl]amide, and stereoisomers and salts thereof.
(R)-{[2-(2-Fluoro-5,11-dihydrodibenzo[b,e][1,4]oxazepine-5-carbonyl)pyrrolidine]-1-yl}-2-(4-pyrrolidinophenyl)ethanone, and stereoisomers and salts thereof.
(R)-1-[(4-Pyrrolidinophenyl)acetyl]pyrrolidine-2-carboxylic acid [2-(2-bromo-5-fluorobenzyloxy)phenyl]amide, and stereoisomers and salts thereof.
Dependencies are inferred from the claim text.